C M Bidwell & Associates LTD Has Lowered Micron Tech (MU) Stake; Aureus Asset Management Has Trimmed Ultragenyx Pharmaceutical Com (RARE) Holding

February 14, 2018 - By Vivian Park

C M Bidwell & Associates Ltd decreased Micron Tech (MU) stake by 89.13% reported in 2017Q3 SEC filing. C M Bidwell & Associates Ltd sold 278,545 shares as Micron Tech (MU)’s stock rose 19.14%. The C M Bidwell & Associates Ltd holds 33,975 shares with $1.34M value, down from 312,520 last quarter. Micron Tech now has $50.27B valuation. The stock increased 1.97% or $0.84 during the last trading session, reaching $43.47. About 29.54 million shares traded. Micron Technology, Inc. (NASDAQ:MU) has risen 176.27% since February 14, 2017 and is uptrending. It has outperformed by 159.57% the S&P500.

Aureus Asset Management Llc decreased Ultragenyx Pharmaceutical Inc Com (RARE) stake by 9.98% reported in 2017Q3 SEC filing. Aureus Asset Management Llc sold 6,555 shares as Ultragenyx Pharmaceutical Inc Com (RARE)’s stock declined 25.28%. The Aureus Asset Management Llc holds 59,115 shares with $3.15M value, down from 65,670 last quarter. Ultragenyx Pharmaceutical Inc Com now has $2.22 billion valuation. The stock increased 5.82% or $2.6 during the last trading session, reaching $47.25. About 318,128 shares traded. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) has declined 6.49% since February 14, 2017 and is downtrending. It has underperformed by 23.19% the S&P500.

Among 21 analysts covering Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), 14 have Buy rating, 1 Sell and 6 Hold. Therefore 67% are positive. Ultragenyx Pharmaceutical Inc had 58 analyst reports since July 27, 2015 according to SRatingsIntel. On Monday, July 13 the stock rating was maintained by SunTrust with “Buy”. Stifel Nicolaus maintained Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) rating on Friday, June 23. Stifel Nicolaus has “Buy” rating and $11100 target. H.C. Wainwright downgraded the shares of RARE in report on Wednesday, April 19 to “Neutral” rating. The rating was maintained by Canaccord Genuity on Tuesday, August 22 with “Buy”. The stock has “Outperform” rating by Credit Suisse on Thursday, January 21. The firm earned “Outperform” rating on Tuesday, May 10 by Wedbush. The rating was initiated by H.C. Wainwright with “Buy” on Tuesday, February 9. The rating was maintained by Wedbush with “Buy” on Friday, January 5. The stock of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) has “Buy” rating given on Thursday, June 29 by Cowen & Co. On Thursday, March 23 the stock rating was downgraded by PiperJaffray to “Neutral”.

Analysts await Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) to report earnings on February, 15. They expect $-2.00 earnings per share, down 14.29% or $0.25 from last year’s $-1.75 per share. After $-1.87 actual earnings per share reported by Ultragenyx Pharmaceutical Inc. for the previous quarter, Wall Street now forecasts 6.95% negative EPS growth.

Aureus Asset Management Llc increased Jpmorgan Chase & Co Com (NYSE:JPM) stake by 6,840 shares to 28,753 valued at $2.75M in 2017Q3. It also upped Merck & Co Inc Com (NYSE:MRK) stake by 7,050 shares and now owns 15,734 shares. Alphabet Inc Cap Stk Cl A was raised too.

Investors sentiment decreased to 1.19 in Q3 2017. Its down 0.65, from 1.84 in 2017Q2. It is negative, as 17 investors sold RARE shares while 40 reduced holdings. 15 funds opened positions while 53 raised stakes. 39.75 million shares or 1.85% less from 40.50 million shares in 2017Q2 were reported. Federated Pa stated it has 0.06% of its portfolio in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Moreover, Profund Limited Liability has 0.04% invested in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Strs Ohio reported 300 shares stake. Ubs Asset Management Americas reported 0% of its portfolio in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Tekla Capital Limited Liability Corporation invested 0.28% of its portfolio in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Invesco Ltd holds 0.01% or 261,757 shares in its portfolio. Cubist Systematic Strategies Lc stated it has 0.03% in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE). Fortaleza Asset holds 0.16% or 1,640 shares. Moreover, Sg Americas Lc has 0% invested in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) for 2,929 shares. Perigon Wealth Mgmt Ltd has 100 shares. Legal & General Gp Plc owns 17,925 shares or 0% of their US portfolio. Td Asset Management Inc owns 0% invested in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) for 31,628 shares. Credit Suisse Ag stated it has 128,023 shares or 0.01% of all its holdings. Manufacturers Life Insur The holds 0% in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) or 30,334 shares. Germany-based Deutsche Fincl Bank Ag has invested 0.01% in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE).

Among 42 analysts covering Micron Technology Inc. (NASDAQ:MU), 36 have Buy rating, 0 Sell and 6 Hold. Therefore 86% are positive. Micron Technology Inc. had 214 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Credit Suisse with “Buy” on Tuesday, September 5. The rating was downgraded by Standpoint Research on Tuesday, November 28 to “Hold”. Bernstein maintained the shares of MU in report on Wednesday, May 18 with “Market Perform” rating. Loop Capital Markets maintained Micron Technology, Inc. (NASDAQ:MU) rating on Thursday, June 15. Loop Capital Markets has “Buy” rating and $4000 target. Mizuho maintained it with “Buy” rating and $3800 target in Wednesday, July 5 report. Cowen & Co maintained the shares of MU in report on Thursday, September 1 with “Outperform” rating. As per Friday, October 2, the company rating was maintained by Credit Suisse. The rating was maintained by M Partners with “Buy” on Thursday, December 14. The firm has “Buy” rating given on Wednesday, October 11 by Summit Redstone Partners. On Friday, June 30 the stock rating was maintained by KeyBanc Capital Markets with “Hold”.

Investors sentiment increased to 1.37 in 2017 Q3. Its up 0.29, from 1.08 in 2017Q2. It increased, as 52 investors sold MU shares while 205 reduced holdings. 114 funds opened positions while 237 raised stakes. 886.67 million shares or 6.47% more from 832.79 million shares in 2017Q2 were reported. Evercore Wealth Mgmt Ltd Liability stated it has 4,860 shares or 0.01% of all its holdings. Eidelman Virant reported 95,865 shares stake. Price T Rowe Md reported 4.69M shares stake. Teacher Retirement Of Texas reported 0.4% stake. Kingdon Capital Management Ltd Liability Company reported 1.44 million shares stake. Hl Fincl Services Limited Liability Company owns 52,049 shares for 0.04% of their portfolio. 17,605 were accumulated by Tiedemann Wealth Mngmt Limited Liability Company. Retirement Systems Of Alabama holds 540,492 shares. Japan-based Mitsubishi Ufj Trust & has invested 0.16% in Micron Technology, Inc. (NASDAQ:MU). Virtus Inv Advisers Inc stated it has 0.11% of its portfolio in Micron Technology, Inc. (NASDAQ:MU). Clinton Gp reported 24,232 shares or 0.1% of all its holdings. Hsbc Public Ltd Co owns 1.24 million shares. Stoneridge Inv Prtnrs Ltd Liability Corp holds 82,818 shares. Rafferty Asset Management Lc holds 369,965 shares. Nomura Hldg Incorporated has invested 0.05% in Micron Technology, Inc. (NASDAQ:MU).

Since August 16, 2017, it had 0 insider buys, and 13 sales for $12.60 million activity. The insider Deboer Scott J sold 16,950 shares worth $701,730. Mondry Lawrence N sold $765,485 worth of stock. Another trade for 3,000 shares valued at $119,583 was sold by BAILEY ROBERT L. Poppen Joel L also sold $3.09M worth of Micron Technology, Inc. (NASDAQ:MU) shares. 118,944 shares were sold by Thorsen Steven L. JR, worth $4.53 million on Friday, September 29. ARNZEN APRIL S sold 327 shares worth $10,507.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>